Clinical Trials in Miami

Showing 7601-7620 of 11,431 trials

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

NCT03210337

The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.

Common Wart

Aclaris Therapeutics, Inc.157 participantsStarted Aug 2017

Scottsdale, Arizona, United States • Rogers, Arkansas, United States • San Diego, California, United States +14 more locations

TERMINATEDPhase 3< 1 mile

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

NCT01975389

This study evaluates the PCSK9 inhibitor, Bococizumab (PF-04950615;RN316), compared to placebo, in reducing the occurrrence of major cardiovascular events, including cardiovascular death, myocardial infarction, stroke, and unstable angina requiring urgent revascularization in high risk subjects who are receiving background lipid lowering therapy and have cholesterol laboratory values of LDL-C \>/= 100 mg/dL (2.6 mmol/L) or non-HDL-C \>/=130 mg/dL (3.4 mmol/L).

Cardiovascular Disease

Pfizer10,564 participantsStarted Oct 2013

Athens, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +1592 more locations

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Find Trials by Condition in Miami

Sodium Management in Acute Neurological Injury

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

MEmbranous Nephropathy Trial Of Rituximab

Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Epicardial Fat in Coronary Artery Disease

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

10003 PRO Current Products

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children